David C. Beers - 13 Apr 2025 Form 4 Insider Report for Celularity Inc (CELU)

Role: Chief Financial Officer
Signature: /s/ David Beers
Issuer symbol: CELU
Transactions as of: 13 Apr 2025
Net transactions value: -$590
Form type: 4
Filing time: 15 Apr 2025, 16:30:24 UTC
Previous filing: 19 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CELU	Class A Common Stock	Options Exercise	$0	+1,025	+5.8%	$0.000000	18,561	13 Apr 2025	Direct	F1
transaction	CELU	Class A Common Stock	Tax liability	$590	-360	-1.9%	$1.64	18,201	13 Apr 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CELU	Restricted Stock Units	Options Exercise	$0	-1,025	-50%	$0.000000	1,025	13 Apr 2025	Class A Common Stock	1,025		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
F2	This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025.
F3	Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
F4	On April 13, 2022, the reporting person was granted 4,101 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.